Haloperidol Prophylaxis in Older Emergency Department Patients
Status:
Completed
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
The investigators propose a multicenter, randomized, double-blinded, placebo-controlled trial
to study the effect of additive low-dose haloperidol prophylaxis on top of exciting care in a
general population of older patients (age 70 years and over) acutely admitted to the hospital
through the emergency department (ED) for general medicine and surgical specialties, and who
are at-risk for developing in-hospital delirium on admission according to the VMS delirium
risk questions (one or more positive answers out of three questions).
The investigators hypothesize that this intervention will reduce the incidence of in-hospital
delirium as well as duration and severity of delirium.